Citigroup’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.4K Sell
52,333
-140,523
-73% -$250K ﹤0.01% 4330
2025
Q4
$274K Sell
192,856
-51,239
-21% -$74.7K ﹤0.01% 3848
2025
Q3
$400K Sell
244,095
-738,372
-75% -$821K ﹤0.01% 3687
2025
Q2
$718K Sell
982,467
-39,414
-4% -$34K ﹤0.01% 3391
2025
Q1
$825K Buy
1,021,881
+541,280
+113% +$623K ﹤0.01% 3382
2024
Q4
$663K Sell
480,601
-38,202
-7% -$42.9K ﹤0.01% 3634
2024
Q3
$540K Buy
518,803
+54,348
+12% +$74.5K ﹤0.01% 3682
2024
Q2
$804K Sell
464,455
-52,261
-10% -$105K ﹤0.01% 3061
2024
Q1
$1.23M Buy
516,716
+142,909
+38% +$352K ﹤0.01% 2858
2023
Q4
$1.24M Sell
373,807
-423,490
-53% -$1.13M ﹤0.01% 2642
2023
Q3
$2.98M Buy
797,297
+289,194
+57% +$1.34M ﹤0.01% 1728
2023
Q2
$2.17M Sell
508,103
-361,210
-42% -$2.13M ﹤0.01% 2141
2023
Q1
$5.95M Buy
869,313
+102,229
+13% +$793K ﹤0.01% 1403
2022
Q4
$6.08M Sell
767,084
-70,631
-8% -$543K ﹤0.01% 1376
2022
Q3
$8.05M Buy
837,715
+68,015
+9% +$688K 0.01% 1254
2022
Q2
$5.57M Buy
769,700
+84,908
+12% +$738K ﹤0.01% 1477
2022
Q1
$8.84M Sell
684,792
-109,604
-14% -$1.39M 0.01% 1359
2021
Q4
$12.7M Buy
794,396
+151,196
+24% +$2.64M 0.01% 1254
2021
Q3
$10.3M Sell
643,200
-211,109
-25% -$3.09M 0.01% 1389
2021
Q2
$11.8M Buy
854,309
+71,811
+9% +$1.02M 0.01% 1302
2021
Q1
$11.4M Buy
782,498
+222,573
+40% +$3.78M 0.01% 1293
2020
Q4
$9.73M Buy
559,925
+32,630
+6% +$581K 0.01% 1575
2020
Q3
$9.67M Buy
527,295
+49,901
+10% +$928K 0.01% 1403
2020
Q2
$8.53M Buy
477,394
+401,905
+532% +$6.8M 0.01% 1423
2020
Q1
$1.22M Buy
75,489
+32,190
+74% +$595K ﹤0.01% 2955
2019
Q4
$780K Sell
43,299
-44,229
-51% -$816K ﹤0.01% 4017
2019
Q3
$1.77M Buy
87,528
+771
+0.9% +$15.4K ﹤0.01% 3004
2019
Q2
$1.92M Sell
86,757
-8,803
-9% -$153K ﹤0.01% 2902
2019
Q1
$1.3M Sell
95,560
-25,136
-21% -$335K ﹤0.01% 3107
2018
Q4
$1.09M Buy
120,696
+74,804
+163% +$866K ﹤0.01% 3301
2018
Q3
$757K Sell
45,892
-121,733
-73% -$2.16M ﹤0.01% 3797
2018
Q2
$2.35M Buy
167,625
+34,091
+26% +$488K ﹤0.01% 2557
2018
Q1
$1.48M Buy
133,534
+95,203
+248% +$1.04M ﹤0.01% 2885
2017
Q4
$337K Buy
38,331
+9,260
+32% +$99.1K ﹤0.01% 4525
2017
Q3
$387K Buy
29,071
+6,204
+27% +$82.1K ﹤0.01% 4360
2017
Q2
$328K Buy
22,867
+22,856
+207,782% +$440K ﹤0.01% 4370
2017
Q1
$0 Sell
11
-57,457
-100% -$1.41M ﹤0.01% 7186
2016
Q4
$1.62M Buy
57,468
+34,971
+155% +$979K ﹤0.01% 3177
2016
Q3
$603K Buy
22,497
+5,064
+29% +$138K ﹤0.01% 3725
2016
Q2
$294K Buy
17,433
+351
+2% +$6.59K ﹤0.01% 4147
2016
Q1
$363K Buy
17,082
+11,273
+194% +$185K ﹤0.01% 4491
2015
Q4
$134K Buy
5,809
+5,801
+72,513% +$149K ﹤0.01% 5093
2015
Q3
$0 Sell
8
-351
-98% -$10.7K ﹤0.01% 7399
2015
Q2
$11K Sell
359
-18,507
-98% -$468K ﹤0.01% 6404
2015
Q1
$577K Buy
18,866
+17,500
+1,281% +$452K ﹤0.01% 3597
2014
Q4
$22K Buy
+1,366
New +$19.3K ﹤0.01% 6162

Other funds holding CHRS